Follow the Gentian Diagnostics ASA share price and the full insider trade history of the company, a listed issuer based in Norway. Shares are listed on the NO market, under the supervision of Oslo Børs. Operating in the Health Care sector, Gentian Diagnostics ASA has recorded 23 public disclosures. Market capitalisation: €573.5m. The latest transaction was reported on 29 May 2026 (Other). Among the most active insiders: Matti Heinonen. The full history is free.
23
Insider Decl.
n/a
Thresholds
€703,164
6 ops.
Buy Volume
€5m
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Gentian Diagnostics ASA Strong Buy (bullish), based on 1 analysts. Average price target: NOK 60.00.
18Σ signal
Buys €703,164€5m Sells
Fundamental score
Ranked 14,207 of 29,064 companies
52.6
score / 100
Value
47
Quality
59
FCF yld5.2%
Earn yld2.2%
EV/EBITDA17.9x
ROE-4.4%
Gross mgn56%
Net mgn7.5%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
100,000 shares@ NOK 67.2174100.0% of flowShareXOSLOSLO:540725
23 of 23 declarations
Acerca de Gentian Diagnostics ASA
Gentian Diagnostics ASA es una empresa dedicada al desarrollo de pruebas de diagnóstico innovadoras para laboratorios médicos. Cotiza en la Bolsa de Valores de Oslo.